Journey to Personalized Medicine

The convergence of clinical innovations and care delivery redesign will enable providers to deliver truly personalized medicine and provide a better patient experience. This study outlines six trends that will drive this future vision.

Executive Summary

Personalized medicine within reach?

Continued advances in genomic sequencing and rumors about the potential availability of the $1,000 genome suggest that personalized medicine may soon be within reach. However, the fragmented nature of care delivery makes it harder for providers to achieve this vision for all patients. To provide patients with the resources they need to make informed treatment decisions, providers must integrate technological advancements in precision therapy and patient care.

Forging the path to the future

Targeted chemotherapy exemplifies opportunities and challenges

Some experts estimate that close to 75% of newly approved anti-cancer agents will be orally administered, many of which will be targeted therapies with an associated companion diagnostic.

These therapies will be more effective and convenient for patients, but most providers are not prepared for reduced infusion center volumes, more lab infrastructure requirements, and the need for more resources to ensure patient compliance and monitor side eff ects.

Plan in advance to cope with disruption

As clinical innovation and care delivery redesign converge, changing volumes and revenue sources will likely disrupt the traditional fee-for-service growth model. New precision treatments in both medical and radiation oncology—and a continued focus on evidence-based therapies—could potentially reduce the total amount of treatment a patient receives.

Care delivery redesign requires patient engagement

Patients will be most engaged in their care when they feel they are able to serve as equal partners in decision making and care delivery.

To establish a partnership, providers should gather patient information beyond traditional clinical data to identify potential barriers to care that might impede optimal outcomes.

Hardwire care coordination across the continuum

Partnering with the patient in shared decision making is only one component of fully engaging patients across their treatment journey.

As risk-based payment models hold providers increasingly responsible for patient outcomes, care coordination across a patient’s immediate care team is essential to minimize duplication of services and ensure continuity of care.

Log in to access this.

Full access to this content is reserved for Oncology Roundtable members.
Log in or learn how membership works.